{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T14:55:47Z","timestamp":1772117747591,"version":"3.50.1"},"reference-count":59,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2019.18554","type":"journal-article","created":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T11:54:27Z","timestamp":1579866867000},"page":"e1918554","source":"Crossref","is-referenced-by-count":18,"title":["Comparison of Mortality and Major Cardiovascular Events Among Adults With Type 2 Diabetes Using Human vs Analogue Insulins"],"prefix":"10.1001","volume":"3","author":[{"given":"Romain","family":"Neugebauer","sequence":"first","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily B.","family":"Schroeder","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Colorado Institute for Health Research, Aurora"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristi","family":"Reynolds","sequence":"additional","affiliation":[{"name":"Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie A.","family":"Schmittdiel","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Loes","sequence":"additional","affiliation":[{"name":"HealthPartners Institute, Minneapolis, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Dyer","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay R.","family":"Desai","sequence":"additional","affiliation":[{"name":"HealthPartners Institute, Minneapolis, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Vazquez-Benitez","sequence":"additional","affiliation":[{"name":"HealthPartners Institute, Minneapolis, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Michael","family":"Ho","sequence":"additional","affiliation":[{"name":"Rocky Mountain Regional Veterans Affairs and University of Colorado (Anschutz) Medical Center, Denver"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff P.","family":"Anderson","sequence":"additional","affiliation":[{"name":"HealthPartners Institute, Minneapolis, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noel","family":"Pimentel","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick J.","family":"O\u2019Connor","sequence":"additional","affiliation":[{"name":"HealthPartners Institute, Minneapolis, Minnesota"},{"name":"HealthPartners Center for Chronic Care Innovation, Minneapolis, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2020,1,24]]},"reference":[{"key":"zoi190698r1","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.2337\/dc19-Sint01","article-title":"Introduction: Standards of Medical Care in Diabetes\u20132019.","volume":"42","author":"American Diabetes Association","year":"2019","journal-title":"Diabetes Care"},{"issue":"12","key":"zoi190698r2","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.2337\/dci18-0033","article-title":"Management of hyperglycemia in type 2 diabetes, 2018: a consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).","volume":"41","author":"Davies","year":"2018","journal-title":"Diabetes Care"},{"issue":"1","key":"zoi190698r3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.2337\/dci17-0057","article-title":"Cardiovascular outcomes trials in type 2 diabetes: where do we go from here? reflections from a Diabetes Care editors\u2019 expert forum.","volume":"41","author":"Cefalu","year":"2018","journal-title":"Diabetes Care"},{"issue":"4","key":"zoi190698r4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes.","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"issue":"19","key":"zoi190698r5","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes.","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"issue":"22","key":"zoi190698r6","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes.","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"issue":"7","key":"zoi190698r7","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes.","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"issue":"12","key":"zoi190698r8","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1001\/jama.2019.13772","article-title":"Effect of linagliptin vs glimepiride on major adverse cardiovascular outcomes in patients with type 2 diabetes: the CAROLINA randomized clinical trial.","volume":"322","author":"Rosenstock","year":"2019","journal-title":"JAMA"},{"issue":"12","key":"zoi190698r9","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1001\/jama.2019.13206","article-title":"Association of treatment with metformin vs sulfonylurea with major adverse cardiovascular events among patients with diabetes and reduced kidney function.","volume":"322","author":"Roumie","year":"2019","journal-title":"JAMA"},{"issue":"3","key":"zoi190698r10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2337\/dc15-0858","article-title":"Severe hypoglycemia requiring medical intervention in a large cohort of adults with diabetes receiving care in US integrated health care delivery systems: 2005-2011.","volume":"39","author":"Pathak","year":"2016","journal-title":"Diabetes Care"},{"issue":"1","key":"zoi190698r11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1001\/jama.2018.7993","article-title":"Association of initiation of basal insulin analogs vs neutral protamine hagedorn insulin with hypoglycemia-related emergency department visits or hospital admissions and with glycemic control in patients with type 2 diabetes.","volume":"320","author":"Lipska","year":"2018","journal-title":"JAMA"},{"issue":"14","key":"zoi190698r12","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.","volume":"329","author":"Nathan","year":"1993","journal-title":"N Engl J Med"},{"issue":"9131","key":"zoi190698r13","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"issue":"24","key":"zoi190698r14","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes.","volume":"358","author":"Gerstein","year":"2008","journal-title":"N Engl J Med"},{"issue":"24","key":"zoi190698r15","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med"},{"issue":"9","key":"zoi190698r16","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1056\/NEJMoa1006524","article-title":"Long-term effects of intensive glucose lowering on cardiovascular outcomes.","volume":"364","author":"Gerstein","year":"2011","journal-title":"N Engl J Med"},{"issue":"15","key":"zoi190698r17","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes.","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"issue":"2","key":"zoi190698r18","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes.","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med"},{"issue":"1","key":"zoi190698r19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1001\/jama.2017.6939","article-title":"Human insulin for type 2 diabetes: an effective, less-expensive option.","volume":"318","author":"Lipska","year":"2017","journal-title":"JAMA"},{"key":"zoi190698r20","article-title":"Short-acting insulin analogues versus regular human insulin for adult, non-pregnant persons with type 2 diabetes mellitus.","volume":"12","author":"Fullerton","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"zoi190698r21","doi-asserted-by":"publisher","first-page":"394","DOI":"10.7326\/M18-1149","article-title":"Medicines for treatment intensification in type 2 diabetes and type of insulin in type 1 and type 2 diabetes in low-resource settings: synopsis of the World Health Organization guidelines on second- and third-line medicines and type of insulin for the control of blood glucose levels in nonpregnant adults with diabetes mellitus.","volume":"169","author":"Roglic","year":"2018","journal-title":"Ann Intern Med"},{"issue":"8","key":"zoi190698r24","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available.","volume":"183","author":"Hern\u00e1n","year":"2016","journal-title":"Am J Epidemiol"},{"issue":"1","key":"zoi190698r25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/1740774511420743","article-title":"Beyond the intention-to-treat in comparative effectiveness research.","volume":"9","author":"Hern\u00e1n","year":"2012","journal-title":"Clin Trials"},{"issue":"14","key":"zoi190698r26","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1056\/NEJMsm1605385","article-title":"Per-protocol analyses of pragmatic trials.","volume":"377","author":"Hern\u00e1n","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"zoi190698r27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/EDE.0b013e3181c1ea43","article-title":"The hazards of hazard ratios.","volume":"21","author":"Hern\u00e1n","year":"2010","journal-title":"Epidemiology"},{"issue":"2","key":"zoi190698r28","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1093\/aje\/kwu253","article-title":"Improving propensity score estimators\u2019 robustness to model misspecification using super learner.","volume":"181","author":"Pirracchio","year":"2015","journal-title":"Am J Epidemiol"},{"issue":"1","key":"zoi190698r29","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1515\/ijb-2015-0028","article-title":"A case study of the impact of data-adaptive versus model-based estimation of the propensity scores on causal inferences from three inverse probability weighting estimators.","volume":"12","author":"Neugebauer","year":"2016","journal-title":"Int J Biostat"},{"issue":"8","key":"zoi190698r30","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1016\/j.jclinepi.2013.01.016","article-title":"Super learning to hedge against incorrect inference from arbitrary parametric assumptions in marginal structural modeling.","volume":"66","author":"Neugebauer","year":"2013","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"zoi190698r31","first-page":"1067","article-title":"Sustaining research networks: the twenty-year experience of the HMO Research Network.","volume":"2","author":"Steiner","year":"2014","journal-title":"EGEMS (Wash DC)"},{"key":"zoi190698r32","article-title":"Construction of a multisite DataLink using electronic health records for the identification, surveillance, prevention, and management of diabetes mellitus: the SUPREME-DM project.","volume":"9","author":"Nichols","year":"2012","journal-title":"Prev Chronic Dis"},{"issue":"5","key":"zoi190698r34","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/01.ede.0000135174.63482.43","article-title":"A structural approach to selection bias.","volume":"15","author":"Hern\u00e1n","year":"2004","journal-title":"Epidemiology"},{"issue":"1-2","key":"zoi190698r35","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1023\/A:1005285815569","article-title":"Association, causation, and marginal structural models.","volume":"121","author":"Robins","year":"1999","journal-title":"Synthese"},{"issue":"5","key":"zoi190698r36","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/00001648-200009000-00012","article-title":"Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men.","volume":"11","author":"Hern\u00e1n","year":"2000","journal-title":"Epidemiology"},{"issue":"14","key":"zoi190698r37","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1002\/sim.6099","article-title":"Targeted learning in real-world comparative effectiveness research with time-varying interventions.","volume":"33","author":"Neugebauer","year":"2014","journal-title":"Stat Med"},{"issue":"11","key":"zoi190698r38","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/pds.v22.11","article-title":"A review of covariate selection for non-experimental comparative effectiveness research.","volume":"22","author":"Sauer","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"zoi190698r39","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1111\/biom.2011.67.issue-4","article-title":"A new criterion for confounder selection.","volume":"67","author":"VanderWeele","year":"2011","journal-title":"Biometrics"},{"issue":"Article 25","key":"zoi190698r40","article-title":"Super learner.","volume":"6","author":"van der Laan","year":"2007","journal-title":"Stat Appl Genet Mol Biol"},{"issue":"4","key":"zoi190698r41","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/EDE.0b013e3181a82501","article-title":"Exhaustion, automation, theory, and confounding.","volume":"20","author":"Joffe","year":"2009","journal-title":"Epidemiology"},{"issue":"5","key":"zoi190698r42","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/sim.6377","article-title":"High-dimensional propensity score algorithm in comparative effectiveness research with time-varying interventions.","volume":"34","author":"Neugebauer","year":"2015","journal-title":"Stat Med"},{"issue":"6","key":"zoi190698r43","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/aje\/kwn164","article-title":"Constructing inverse probability weights for marginal structural models.","volume":"168","author":"Cole","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"1","key":"zoi190698r44","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1177\/0962280210386207","article-title":"Diagnosing and responding to violations in the positivity assumption.","volume":"21","author":"Petersen","year":"2012","journal-title":"Stat Methods Med Res"},{"issue":"3","key":"zoi190698r45","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006341","article-title":"Comparative cardiovascular morbidity and mortality in patients taking different insulin regimens for type 2 diabetes: a systematic review.","volume":"5","author":"Price","year":"2015","journal-title":"BMJ Open"},{"issue":"3","key":"zoi190698r46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151910","article-title":"All-cause and cause-specific mortality among users of basal insulins NPH, detemir, and glargine.","volume":"11","author":"Strandberg","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"zoi190698r47","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1055\/s-00000017","article-title":"Macro- and microvascular outcomes in patients with type 2 diabetes treated with rapid-acting insulin analogues or human regular insulin: a retrospective database analysis.","volume":"122","author":"Rathmann","year":"2014","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"2","key":"zoi190698r48","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005613.pub3","article-title":"Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus.","author":"Horvath","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"zoi190698r49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079762","article-title":"Lower rate of cardiovascular complications in patients on bolus insulin analogues: a retrospective population-based cohort study.","volume":"8","author":"Cammarota","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"zoi190698r50","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s11065-008-9066-x","article-title":"Methodological challenges in causal research on racial and ethnic patterns of cognitive trajectories: measurement, selection, and bias.","volume":"18","author":"Glymour","year":"2008","journal-title":"Neuropsychol Rev"},{"issue":"12","key":"zoi190698r51","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1093\/aje\/kwj149","article-title":"Variable selection for propensity score models.","volume":"163","author":"Brookhart","year":"2006","journal-title":"Am J Epidemiol"},{"issue":"4","key":"zoi190698r52","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/EDE.0b013e3181a663cc","article-title":"High-dimensional propensity score adjustment in studies of treatment effects using health care claims data.","volume":"20","author":"Schneeweiss","year":"2009","journal-title":"Epidemiology"},{"issue":"4","key":"zoi190698r53","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1001\/jama.2018.21364","article-title":"Implementation of a health plan program for switching from analogue to human insulin and glycemic control among Medicare beneficiaries with type 2 diabetes.","volume":"321","author":"Luo","year":"2019","journal-title":"JAMA"},{"issue":"4","key":"zoi190698r54","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1001\/jama.2018.21356","article-title":"Insulin analogues for type 2 diabetes.","volume":"321","author":"Lipska","year":"2019","journal-title":"JAMA"},{"issue":"4","key":"zoi190698r55","doi-asserted-by":"publisher","first-page":"468","DOI":"10.2337\/dc16-0985","article-title":"Trends in drug utilization, glycemic control, and rates of severe hypoglycemia, 2006-2013.","volume":"40","author":"Lipska","year":"2017","journal-title":"Diabetes Care"},{"issue":"3","key":"zoi190698r56","doi-asserted-by":"publisher","first-page":"165","DOI":"10.7326\/M18-0443","article-title":"Comparative benefits and harms of basal insulin analogues for type 2 diabetes: a systematic review and network meta-analysis.","volume":"169","author":"Madenidou","year":"2018","journal-title":"Ann Intern Med"},{"issue":"8","key":"zoi190698r58","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1056\/NEJMoa1615692","article-title":"Efficacy and safety of degludec versus glargine in type 2 diabetes.","volume":"377","author":"Marso","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"zoi190698r59","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-009421","article-title":"Safety and efficacy of insulin glargine 300 \u00b5\/mL compared with other basal insulin therapies in patients with type 2 diabetes mellitus: a network meta-analysis.","volume":"6","author":"Freemantle","year":"2016","journal-title":"BMJ Open"},{"key":"zoi190698r22","volume-title":"Guidelines on Second- and Third-Line Medicines and Type of Insulin for the Control of Blood Glucose Levels in Non-pregnant Adults With Diabetes Mellitus","author":"World Health Organization (WHO)","year":"2018"},{"key":"zoi190698r23","first-page":"1","author":"Robins","year":"1998"},{"key":"zoi190698r33","unstructured":"Kaiser Permanente Division of Research, Northern California; LeongTK, TabadaGH, YangJM, ZhuZ, NeugebauerRS. MSMstructure SAS macro version 1.0.4. https:\/\/divisionofresearch.kaiserpermanente.org\/projects\/biostatistics\/causalinferencesoftware. Published March 16, 2017. Accessed November 22, 2019."},{"key":"zoi190698r57","unstructured":"Insulins for type 2 diabetes. The Medical Letter on Drugs and Therapeutics, issue 1571. https:\/\/secure.medicalletter.org\/article-share?a=1571a&p=tml&title=Insulins%20for%20Type%202%20Diabetes&cannotaccesstitle=1. Published May 6, 2019. Accessed December 3, 2019."}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2759275\/neugebauer_2020_oi_190698.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T11:54:32Z","timestamp":1579866872000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2759275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,24]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.18554","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737269730.793570550","asserted-by":"object"}]},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,24]]}}}